Area of research
Hepatology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Clear cell renal cell carcinoma, with related work in Downregulation and upregulation, Hepatocellular carcinoma, Lenvatinib. Notable publications include 'The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study', 'Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer', and 'E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer'.
MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker
Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)
PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway
Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study
Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective study
One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS
E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer
Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt
Hexagonal NaxWO3 nanocrystals with reversible valence states for microwave thermal and chemodynamic combined cancer therapy
The Relationship and Changes of Liver Blood Supply, Portal Pressure Gradient, and Liver Volume following TIPS in Cirrhosis
Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy
The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Targeted delivery of Bi2Se3 Nanoflowers to orthotopic liver tumor via transarterial infusion for enhanced microwave ablation sensibilization
Reduced MAGI3 level by HPV18E6 contributes to Wnt/β‐catenin signaling activation and cervical cancer progression
NHERF4 hijacks Mas-mediated PLC/AKT signaling to suppress the invasive potential of clear cell renal cell carcinoma cells
Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival
Body mass index changes after transjugular intrahepatic portosystemic shunt in individuals with cirrhosis
Prognostic significance of controlling nutritional status score- based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation
Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer
HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1
PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation
<scp>SERPINH</scp>1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker
Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma
MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells
Clinical Efficacy of Percutaneous Transluminal Renal Artery Stenting for the Treatment of Renovascular Hypertension Associated with Takayasu Arteritis
EBP50 Phosphorylation by Cdc2/Cyclin B Kinase Affects Actin Cytoskeleton Reorganization and Regulates Functions of Human Breast Cancer Cell Line MDA-MB-231
Stabilization of the angiotensin-(1–7) receptor Mas through interaction with PSD95